Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

Conclusion: Monthly methylprednisolone pulse treatment was safe, but had no effect on the primary outcome. However, improvements in secondary clinical and MRI outcome measures suggest that this treatment regimen may have a beneficial effect in progressive MS.

http://msj.sagepub.com/cgi/content/abstract/22/7/926?rss=1

Source: Multiple Sclerosis - June 1, 2016 Category: Neurology Authors: Ratzer, R., Iversen, P., Börnsen, L., Dyrby, T. B., Romme Christensen, J., Ammitzboll, C., Madsen, C. G., Garde, E., Lyksborg, M., Andersen, B., Hyldstrup, L., Sorensen, P. S., Siebner, H. R., Sellebjerg, F. Tags: Original Research Papers Source Type: research